Mark Thierer - 06 Jun 2024 Form 4 Insider Report for P3 Health Partners Inc. (PIII)

Reporting relationship: Director
Issuer ticker: PIII
Reported as of: 06 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2024, 17:42:15 UTC
Prior SEC filing: 25 Jan 2024
Next SEC filing: 23 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Leslie Fisher, as attorney-in-fact

Key filing fact

Mark Thierer filed Form 4 for P3 Health Partners Inc. (PIII) on 10 Jun 2024.

Key facts

This page summarizes Mark Thierer's Form 4 filing for P3 Health Partners Inc. (PIII).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2024, 17:42.

Change

Previous filing in this sequence was filed on 25 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PIII transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +965,279
Change %
Price: $0.000000
Shares after: 965,279
Date: 06 Jun 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 965,279
Exercise price: $0.5461
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and becomes exercisable on the earlier of (i) June 6, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

SEC remarks

Exhibit 24 - Power of Attorney